好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Long-Term Safety and Tolerability of High Dose Donepezil (23 mg/Day) in Moderate-to-Severe Alzheimer's Disease: A 12-Month Open-Label Study
Aging and Dementia
(-)
223
Authors/Disclosures
Martin R. Farlow, MD, FAAN (Indiana University School of Medicine) No disclosure on file
Christoph A. Mayer, MD, PhD (Neurologie am Kaiserplatz) No disclosure on file
Kara J. Wyant, MD (University of Michigan, Neurology Dept) Dr. Wyant has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Wyant has received research support from NIH-DHHS-US, NeuroNEXT. The institution of Dr. Wyant has received research support from PhotoPharmics, Inc. The institution of Dr. Wyant has received research support from Michael J Fox Foundation. The institution of Dr. Wyant has received research support from UCB BioPharma. Dr. Wyant has received publishing royalties from a publication relating to health care. Dr. Wyant has received publishing royalties from a publication relating to health care. Dr. Wyant has received publishing royalties from a publication relating to health care.
Harry Ramos, MD (Mount Sinai Hospital) No disclosure on file
Warachal Faison, MD (Pfizer Inc.) No disclosure on file
No disclosure on file